CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,113	10,092	5,906	2,386	3,955	11,838
Short-Term Investments	29,550	22,550	32,990	55,377	47,500	3,000
Trading Asset Securities	6,017	7,465	-	-	10,095	9,989
Cash & Short-Term Investments	37,680	40,107	38,896	57,763	61,550	24,827
Cash Growth	2.80%	3.11%	-32.66%	-6.15%	147.92%	179.65%
Accounts Receivable	-0	-0	0	-0	-0	-0
Other Receivables	524.15	399.87	453.87	607.81	266.9	188.2
Receivables	524.15	399.87	453.87	607.8	266.9	188.2
Prepaid Expenses	340.11	106.63	94.23	117.1	12.94	8.52
Other Current Assets	3,979	3,977	3,042	429	17.07	13.91
Total Current Assets	42,524	44,590	42,486	58,917	61,847	25,037
Property, Plant & Equipment	1,123	1,120	1,644	1,543	1,032	586.81
Long-Term Investments	1,069	1,069	674.6	440	2,300	-
Other Intangible Assets	192.96	174.67	43.58	39.91	21.77	28.86
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	289.97	294.39	270.9	129.08	112.5	94.43
Total Assets	45,199	47,248	45,119	61,069	65,313	25,747
Accrued Expenses	129.31	129.31	146.74	77.43	60.77	63
Short-Term Debt	5,230	4,950	-	23,240	20,717	-
Current Portion of Leases	8.62	8.35	162.92	381.21	112.8	101.77
Other Current Liabilities	4,517	4,526	500.53	3,090	3,816	4,641
Total Current Liabilities	9,885	9,613	810.18	26,789	24,706	4,806
Long-Term Debt	4,859	4,627	3,975	-	-	18,610
Long-Term Leases	1.55	3.81	188.65	16.53	16.14	128.94
Other Long-Term Liabilities	3,668	3,662	3,525	15.09	237.52	186.68
Total Liabilities	20,031	19,526	9,702	27,703	25,698	24,174
Common Stock	13,412	13,412	13,366	13,215	13,215	11,194
Additional Paid-In Capital	79,687	79,687	76,782	72,576	72,576	18,404
Retained Earnings	-68,494	-65,920	-55,457	-53,615	-46,921	-28,335
Comprehensive Income & Other	563.17	542.97	725.68	1,190	745.6	310.07
Shareholders' Equity	25,169	27,722	35,417	33,366	39,615	1,573
Total Liabilities & Equity	45,199	47,248	45,119	61,069	65,313	25,747
Total Debt	10,099	9,589	4,327	23,638	20,846	18,840
Net Cash (Debt)	27,581	30,518	34,569	34,125	40,704	5,986
Net Cash Growth	-14.06%	-11.72%	1.30%	-16.16%	579.94%	64.00%
Net Cash Per Share	1028.37	1138.75	1304.13	1290.78	1745.71	333.84
Filing Date Shares Outstanding	26.82	26.82	26.73	26.43	26.43	17.93
Total Common Shares Outstanding	26.82	26.82	26.73	26.43	26.43	17.93
Working Capital	32,639	34,977	41,676	32,128	37,141	20,231
Book Value Per Share	938.26	1033.46	1324.89	1262.45	1498.91	87.72
Tangible Book Value	24,976	27,548	35,373	33,326	39,593	1,544
Tangible Book Value Per Share	931.07	1026.95	1323.26	1260.94	1498.09	86.11
Land	95.09	95.09	95.09	95.09	95.09	95.09
Buildings	402.68	402.68	402.68	402.68	402.68	402.68
Machinery	2,188	2,086	1,933	1,622	1,079	410.3

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.